Athersys Inc (ATHXQ)

[goupupup]

An old classmate of GVB...I would love to see GVB reach out to this individual and have a conversation about Multistem. If you don't have that rigour, the well-designed rigorously conducted, ideally double-blind, randomized controlled trials to minimize or even eliminate that bias, then you can't get a robust answer to these critical questions. Larry Tsai Global Head of Respiratory and Rheumatology Product Development, Roche Genentech Stanford University 1989-1993)"One of the things that makes this company special is that everyone really believes in this mission of trying to bring transformative medications to patients with unmet medical needs. It's hard to argue that there's more pressing medical need right now in the world than COVID-19."

https://www.roche.com/research_and_development/who_we_are_how_we_work/clinical_trials/larry-tsai.htm